This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saitama, JP (1999)
- Iruma, JP (2000)
Company Filing History:
Years Active: 1999-2000
Title: Tadamasa Saitoh: Innovator in Pharmaceutical Compounds
Introduction
Tadamasa Saitoh is a notable inventor based in Iruma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzamide compounds. With a total of 2 patents, Saitoh's inventions have the potential to impact various therapeutic areas.
Latest Patents
One of Saitoh's latest patents focuses on benzamide compounds and their pharmaceutical applications. These compounds are defined by specific formulas and include isomers and pharmaceutically acceptable acid addition salts. The patent details pharmaceutical compositions that contain a therapeutically effective amount of these compounds, which are useful in treating conditions such as hypertension, angina pectoris, asthma, and renal and peripheral circulatory disturbances. The compounds exhibit strong smooth muscle relaxing action and have been shown to provide long-lasting improvements in circulation, making them valuable alternatives to conventional calcium antagonists.
Career Highlights
Throughout his career, Tadamasa Saitoh has worked with prominent companies in the pharmaceutical industry, including Yoshitomi Pharmaceutical Industries, Ltd. and Mitsubishi Tanabe Pharma Corporation. His experience in these organizations has contributed to his expertise in developing innovative therapeutic agents.
Collaborations
Saitoh has collaborated with notable colleagues such as Keiji Yamagami and Masanori Minoguchi. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Tadamasa Saitoh's contributions to the development of benzamide compounds highlight his role as an innovator in the pharmaceutical industry. His work has the potential to provide effective treatments for various medical conditions, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile